Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Minority Interest (2016 - 2025)

Marimed has reported Minority Interest over the past 13 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly Minority Interest fell 6.22% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.9 million through Dec 2025, down 6.22% year-over-year, with the annual reading at -$1.9 million for FY2025, 6.22% down from the prior year.
  • Minority Interest was -$1.9 million for Q4 2025 at Marimed, down from -$1.8 million in the prior quarter.
  • Over five years, Minority Interest peaked at -$569574.0 in Q1 2021 and troughed at -$1.9 million in Q4 2025.
  • The 5-year median for Minority Interest is -$1.6 million (2022), against an average of -$1.5 million.
  • The largest YoY upside for Minority Interest was 5.39% in 2022 against a maximum downside of 182.84% in 2022.
  • A 5-year view of Minority Interest shows it stood at -$1.6 million in 2021, then increased by 3.33% to -$1.5 million in 2022, then decreased by 9.2% to -$1.6 million in 2023, then fell by 6.18% to -$1.8 million in 2024, then dropped by 6.22% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Minority Interest are -$1.9 million (Q4 2025), -$1.8 million (Q3 2025), and -$1.8 million (Q2 2025).